Ketogenic diet alleviates brain iron deposition and cognitive dysfunction via Nrf2-mediated ferroptosis pathway in APP/PS1 mouse

[1]  Jinglin Zhao,et al.  Ketogenic diet and calorie-restricted diet attenuate ischemic brain injury via UBR4 and downstream CamkⅡ/TAK1/JNK signaling , 2023, Journal of Functional Foods.

[2]  M. Janahmadi,et al.  Role of amyloid beta (25-35) neurotoxicity in the ferroptosis and necroptosis as modalities of regulated cell death in Alzheimer's Disease. , 2022, Neurotoxicology.

[3]  Yuan Zhang,et al.  Iron dyshomeostasis and ferroptosis in Alzheimer’s disease: Molecular mechanisms of cell death and novel therapeutic drugs and targets for AD , 2022, Frontiers in Pharmacology.

[4]  Ye Tao,et al.  Ketogenic Diet: An Effective Treatment Approach for Neurodegenerative Diseases , 2022, Current neuropharmacology.

[5]  Anonymous,et al.  2022 Alzheimer's disease facts and figures , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[6]  L. Baum,et al.  Effects of Deferasirox in Alzheimer’s Disease and Tauopathy Animal Models , 2022, Biomolecules.

[7]  G. Chen,et al.  Identification of Ferroptosis-Related Genes in Alzheimer’s Disease Based on Bioinformatic Analysis , 2022, Frontiers in Neuroscience.

[8]  M. Murakami,et al.  Molecular Mechanisms Underlying the Bioactive Properties of a Ketogenic Diet , 2022, Nutrients.

[9]  H. Qin,et al.  Ketogenic diet for human diseases: the underlying mechanisms and potential for clinical implementations , 2022, Signal Transduction and Targeted Therapy.

[10]  Lin F. Yang,et al.  Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019 , 2022, The Lancet. Public health.

[11]  X. Deng,et al.  Ketogenic diet ameliorates cognitive impairment and neuroinflammation in a mouse model of Alzheimer’s disease , 2021, CNS neuroscience & therapeutics.

[12]  H. Kolb,et al.  Ketone bodies: from enemy to friend and guardian angel , 2021, BMC Medicine.

[13]  Xuejiao Chang,et al.  Iron Homeostasis Disorder and Alzheimer’s Disease , 2021, International journal of molecular sciences.

[14]  F. Mirzaei,et al.  Deferoxamine preconditioning enhances the protective effects of stem cells in streptozotocin-induced Alzheimer's disease. , 2021, Life sciences.

[15]  Ling-Qiang Zhu,et al.  Ferroptosis, a Potential Therapeutic Target in Alzheimer’s Disease , 2021, Frontiers in Cell and Developmental Biology.

[16]  Lan Zhang,et al.  Tetrahydroxy stilbene glycoside ameliorates Alzheimer's disease in APP/PS1 mice via glutathione peroxidase related ferroptosis. , 2021, International immunopharmacology.

[17]  A. Ünalp,et al.  The effect of ketogenic diet on serum lipid concentrations in children with medication resistant epilepsy , 2021, Seizure.

[18]  Yanxin Shen,et al.  The Potential Role of Ferroptosis in Alzheimer's Disease. , 2021, Journal of Alzheimer's disease : JAD.

[19]  A. Belaidi,et al.  Ferroptosis: mechanisms and links with diseases , 2021, Signal Transduction and Targeted Therapy.

[20]  Junxia Xie,et al.  New Insights into the Role of Ferritin in Iron Homeostasis and Neurodegenerative Diseases , 2021, Molecular Neurobiology.

[21]  A. Bianco,et al.  Effects of Two Months of Very Low Carbohydrate Ketogenic Diet on Body Composition, Muscle Strength, Muscle Area, and Blood Parameters in Competitive Natural Body Builders , 2021, Nutrients.

[22]  J. Schneider,et al.  Regional brain iron associated with deterioration in Alzheimer's disease: A large cohort study and theoretical significance , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[23]  P. Nelson,et al.  Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer’s disease , 2021, Cell Death & Differentiation.

[24]  T. Fulop,et al.  The effect of a 6-month ketogenic medium-chain triglyceride supplement on plasma cardiometabolic and inflammatory markers in mild cognitive impairment. , 2020, Prostaglandins, leukotrienes, and essential fatty acids.

[25]  W. Chen,et al.  Ferritin reduction is essential for cerebral ischemia-induced hippocampal neuronal death through p53/SLC7A11-mediated ferroptosis , 2020, Brain Research.

[26]  P. Edison,et al.  Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? , 2020, Nature Reviews Neurology.

[27]  S. Bydlowski,et al.  Ferroptosis Mechanisms Involved in Neurodegenerative Diseases , 2020, International journal of molecular sciences.

[28]  J. Rungby,et al.  Effects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases , 2020, International journal of molecular sciences.

[29]  L. Zhuang,et al.  Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy , 2020, Protein & Cell.

[30]  T. Raife,et al.  β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer’s disease pathology , 2020, Journal of neuroinflammation.

[31]  Erqun Song,et al.  Fostered Nrf2 expression antagonizes iron overload and glutathione depletion to promote resistance of neuron-like cells to ferroptosis. , 2020, Toxicology and applied pharmacology.

[32]  P. So,et al.  Iron dyshomeostasis, lipid peroxidation and perturbed expression of cystine/glutamate antiporter in Alzheimer’s disease: Evidence of ferroptosis , 2020, Redox biology.

[33]  B. de Strooper,et al.  The β-Secretase BACE1 in Alzheimer’s Disease , 2020, Biological Psychiatry.

[34]  Junjian Zhang,et al.  Iron Metabolism, Ferroptosis, and the Links With Alzheimer’s Disease , 2020, Frontiers in Neuroscience.

[35]  Hugo Geerts,et al.  Challenges in Alzheimer's Disease Drug Discovery and Development: The Role of Modeling, Simulation, and Open Data , 2020, Clinical pharmacology and therapeutics.

[36]  Can Liu,et al.  Mitochondria regulation in ferroptosis. , 2019, European journal of cell biology.

[37]  B. Stockwell,et al.  The development of the concept of ferroptosis. , 2019, Free radical biology & medicine.

[38]  H. Kawabata.  Transferrin and transferrin receptors update , 2019, Free radical biology & medicine.

[39]  J. Schneider,et al.  Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology , 2019, Molecular Psychiatry.

[40]  Haiying Li,et al.  Glutathione peroxidase 4 participates in secondary brain injury through mediating ferroptosis in a rat model of intracerebral hemorrhage , 2018, Brain Research.

[41]  M. Carrara,et al.  Dexamethasone counteracts hepatic inflammation and oxidative stress in cholestatic rats via CAR activation , 2018, PloS one.

[42]  Mou-wang Zhou,et al.  Ketogenic diet attenuates oxidative stress and inflammation after spinal cord injury by activating Nrf2 and suppressing the NF-κB signaling pathways , 2018, Neuroscience Letters.

[43]  Scott Ayton,et al.  Iron and Alzheimer's Disease: An Update on Emerging Mechanisms. , 2018, Journal of Alzheimer's disease : JAD.

[44]  Aikseng Ooi,et al.  The Roles of NRF2 in Modulating Cellular Iron Homeostasis , 2017, Antioxidants & redox signaling.

[45]  W. Frey,et al.  Intranasal deferoxamine affects memory loss, oxidation, and the insulin pathway in the streptozotocin rat model of Alzheimer's disease , 2017, Journal of the Neurological Sciences.

[46]  Qitao Ran,et al.  Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration , 2017, Redox biology.

[47]  G. Rose,et al.  Glucose tolerance and insulin sensitivity are impaired in APP/PS1 transgenic mice prior to amyloid plaque pathogenesis and cognitive decline , 2017, Experimental Gerontology.

[48]  Aritri Bir,et al.  The Oral Iron Chelator, Deferasirox, Reverses the Age-Dependent Alterations in Iron and Amyloid-β Homeostasis in Rat Brain: Implications in the Therapy of Alzheimer's Disease. , 2015, Journal of Alzheimer's disease : JAD.

[49]  F. Liu,et al.  The neuroprotective effects of β-hydroxybutyrate on Aβ-injected rat hippocampus in vivo and in Aβ-treated PC-12 cells in vitro , 2015, Free radical research.

[50]  A. Bianco,et al.  Effects of n-3 Polyunsaturated Fatty Acids (ω-3) Supplementation on Some Cardiovascular Risk Factors with a Ketogenic Mediterranean Diet , 2015, Marine drugs.

[51]  Susan M Resnick,et al.  Changes in Brain Function Occur Years before the Onset of Cognitive Impairment , 2013, The Journal of Neuroscience.

[52]  D. Lane,et al.  Mammalian iron homeostasis in health and disease: uptake, storage, transport, and molecular mechanisms of action. , 2013, Antioxidants & redox signaling.

[53]  M. Murphy,et al.  A ketogenic diet improves motor performance but does not affect β-amyloid levels in a mouse model of Alzheimer's Disease , 2013, Brain Research.

[54]  R. Nelson,et al.  Hyperlipidemia as a risk factor for cardiovascular disease. , 2013, Primary care.

[55]  Pu Wang,et al.  Deferoxamine inhibits iron induced hippocampal tau phosphorylation in the Alzheimer transgenic mouse brain , 2013, Neurochemistry International.

[56]  M. R. Lamprecht,et al.  Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death , 2012, Cell.

[57]  Manisha N. Patel,et al.  Acute oxidative stress and systemic Nrf2 activation by the ketogenic diet , 2010, Neurobiology of Disease.

[58]  M. Schrag,et al.  Deferiprone reduces amyloid-β and tau phosphorylation levels but not reactive oxygen species generation in hippocampus of rabbits fed a cholesterol-enriched diet. , 2012, Journal of Alzheimer's disease : JAD.

[59]  P. Maher,et al.  Regulation of xCT expression and system $$ x_{\text{c}}^{ - } $$ function in neuronal cells , 2011, Amino Acids.